Bioaxia Life Sciences Fund LP is a hedge fund based in New York, New York. According to its most recent Form D, filed Oct 27, 2026, the fund has sold $3,260,000 of interests to 6 investors since its first sale in Sep 2025. The minimum investment it accepts from an outside investor is $500,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Bioaxia Life Sciences Fund GP LLC; Bioaxia LLC; Douglas Eby.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $3,260,000Cumulative sales reported on Form D
- Investors
- 6
- First sale
- Sep 30, 2025
- Minimum investment
- $500,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Bioaxia Life Sciences Fund GP LLC; Bioaxia LLC; Douglas Eby
- Latest Form D
- Oct 27, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Bioaxia Life Sciences Fund LP
What is the minimum investment for Bioaxia Life Sciences Fund LP?
According to its latest Form D, filed Oct 27, 2026, the minimum investment Bioaxia Life Sciences Fund LP accepts from an outside investor is $500,000.
Who can invest in Bioaxia Life Sciences Fund LP?
Bioaxia Life Sciences Fund LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Bioaxia Life Sciences Fund LP raised?
Bioaxia Life Sciences Fund LP reports $3,260,000 sold from 6 investors on its Form D filed Oct 27, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Bioaxia Life Sciences Fund LP based?
Bioaxia Life Sciences Fund LP is based in New York, New York.
When did Bioaxia Life Sciences Fund LP launch?
Bioaxia Life Sciences Fund LP reports its first sale in Sep 2025, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every hedge fund
Raised more than 16% of the 2,544 hedge funds based in New York, and more than 12% of all 10,308 that report sales.